tirzepatide launch date Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders How Many People Are on

GLP-1s were originally developed to treat type 2 diabetes and are now increasingly used to treat obesity (1)

Metabolic processes leave their 'waste' in the cells, and chemicals from air, water and food also enter the body

It calls the evidence limited but growing, with case reports showing both tolerable use and flares

In the case of eWAT, an increase in endogenous fatty acids following adherence to a HFD activates two sensors within adipocytes, Toll-like receptor 4(TLR4) and inflammasomes, which causes an influx of neutrophils to enter the eWAT, leading to increased levels of chemokine and cytokine expression (132)

S.DimarcoP

Mild to moderate nausea and appetite changes are expected during the first 12 weeks